DK452682A - Hidtil ukendte imidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem - Google Patents
Hidtil ukendte imidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem Download PDFInfo
- Publication number
- DK452682A DK452682A DK452682A DK452682A DK452682A DK 452682 A DK452682 A DK 452682A DK 452682 A DK452682 A DK 452682A DK 452682 A DK452682 A DK 452682A DK 452682 A DK452682 A DK 452682A
- Authority
- DK
- Denmark
- Prior art keywords
- unidentified
- procedures
- preparation
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813141063 DE3141063A1 (de) | 1981-10-13 | 1981-10-13 | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK452682A true DK452682A (da) | 1983-04-14 |
Family
ID=6144208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK452682A DK452682A (da) | 1981-10-13 | 1982-10-13 | Hidtil ukendte imidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US4466976A (da) |
| EP (1) | EP0077024B1 (da) |
| JP (1) | JPS58109474A (da) |
| AT (1) | ATE28872T1 (da) |
| CA (1) | CA1195325A (da) |
| DE (2) | DE3141063A1 (da) |
| DK (1) | DK452682A (da) |
| GB (1) | GB2108499A (da) |
| IE (1) | IE54005B1 (da) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2550532B1 (fr) * | 1983-08-11 | 1987-12-04 | Synthelabo | Derives de l'indole, leur preparation et leur application en therapeutique |
| EP0141686B1 (fr) * | 1983-08-11 | 1987-09-09 | Synthelabo | Dérivés de l'indole, leur préparation et leur application en thérapeutique |
| US4659726A (en) * | 1984-04-19 | 1987-04-21 | Kanebo, Ltd. | Novel 4,5-Bis (4-methoxyphenyl)-2-(pyrrol-2-yl) thiazoles and pharmaceutical composition containing the same |
| FR2577223B1 (fr) * | 1985-02-08 | 1987-02-27 | Synthelabo | Derives de l'indole, leur preparation et leur application en therapeutique |
| EP0211698B1 (fr) * | 1985-02-08 | 1991-01-30 | Synthelabo | Dérivés de (dihydro-4,5 1H-imidazolyl-2)-2 dihydro-2,3 indole, leur préparation et leur application en thérapeutique |
| FR2577224B1 (fr) * | 1985-02-08 | 1987-02-27 | Synthelabo | Derives de phenyl-1 indole, leur preparation et leur application en therapeutique |
| US5147863A (en) * | 1985-11-25 | 1992-09-15 | Merrell Dow Pharmaceuticals Inc. | 2,2'-bi-1H-imidazoles |
| DE3620430A1 (de) * | 1986-06-18 | 1987-12-23 | Basf Ag | Verfahren zur herstellung von hexaarylbisimidazolen |
| US5665752A (en) * | 1988-07-26 | 1997-09-09 | Sankyo Company, Limited | Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents |
| US5354768A (en) * | 1988-07-26 | 1994-10-11 | Sankyo Company, Limited | Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents |
| JPH02101065A (ja) * | 1988-10-06 | 1990-04-12 | Tanabe Seiyaku Co Ltd | イミダゾリン誘導体及びその製法 |
| US5916891A (en) | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
| US6046208A (en) * | 1996-01-11 | 2000-04-04 | Smithkline Beecham Corporation | Substituted imidazole compounds |
| AR017200A1 (es) * | 1997-12-23 | 2001-08-22 | Astrazeneca Ab | Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos |
| SE9800835D0 (sv) | 1998-03-13 | 1998-03-13 | Astra Ab | New Compounds |
| DE19842833B4 (de) | 1998-09-18 | 2005-04-14 | Merckle Gmbh | 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung |
| US6492406B1 (en) | 1999-05-21 | 2002-12-10 | Astrazeneca Ab | Pharmaceutically active compounds |
| SE9902387D0 (sv) | 1999-06-22 | 1999-06-22 | Astra Ab | New pharmaceutically active compounds |
| US6346625B1 (en) | 1999-06-23 | 2002-02-12 | Astrazeneca Ab | Protein kinase inhibitors |
| DE19948417A1 (de) * | 1999-10-07 | 2001-04-19 | Morphochem Ag | Imidazol-Derivate und ihre Verwendung als Arzneimittel |
| DE10107683A1 (de) * | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| ES2497116T3 (es) * | 2002-08-19 | 2014-09-22 | Lorus Therapeutics Inc. | Imidazoles 2,4,5-trisustituidos y su uso como agentes antimicrobianos |
| DE10238045A1 (de) * | 2002-08-20 | 2004-03-04 | Merckle Gmbh Chem.-Pharm. Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| AU2004289539C1 (en) | 2003-11-14 | 2012-06-07 | Lorus Therapeutics Inc. | Aryl imidazoles and their use as anti-cancer agents |
| US8148392B2 (en) | 2005-05-25 | 2012-04-03 | Lorus Therapeutics Inc. | 2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer |
| EP1894925A1 (en) * | 2006-08-24 | 2008-03-05 | Merckle Gmbh | Imidazole compounds having an antiinflammatory effect |
| JP2016516082A (ja) | 2013-03-20 | 2016-06-02 | アプトース バイオサイエンシーズ， インコーポレイテッド | ２−置換イミダゾ［４，５−ｄ］フェナントロリン誘導体及び癌の治療におけるそれらの使用 |
| DK3052102T3 (da) | 2013-10-04 | 2020-03-09 | Aptose Biosciences Inc | Sammensætninger til behandling af cancere |
| KR20200096914A (ko) | 2017-10-30 | 2020-08-14 | 압토스 바이오사이언시스 인코포레이티드 | 암 치료용 아릴 이미다졸 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH554867A (de) * | 1970-12-04 | 1974-10-15 | Ciba Geigy Ag | Verfahren zur herstellung von neuen imidazolderivaten. |
| US3708598A (en) * | 1970-07-10 | 1973-01-02 | Sandoz Ag | Substituted 2,4-(omega-aminoalkoxy)phenyl imidazoles as cholesterol reducing agents |
| US3707475A (en) * | 1970-11-16 | 1972-12-26 | Pfizer | Antiinflammatory imidazoles |
| FR2364941A1 (fr) * | 1976-09-17 | 1978-04-14 | Inst Francais Du Petrole | Nouvelles resines aromatiques thermodurcissables et polymeres thermostables en derivant |
| EP0005219B1 (en) * | 1978-04-24 | 1981-07-22 | A/S Dumex (Dumex Ltd.) | Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them |
| DE3025484A1 (de) * | 1980-07-03 | 1982-02-04 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| JPS57150667A (en) * | 1981-02-12 | 1982-09-17 | Wellcome Found | Antithrombotic |
-
1981
- 1981-10-13 DE DE19813141063 patent/DE3141063A1/de not_active Withdrawn
-
1982
- 1982-10-07 AT AT82109252T patent/ATE28872T1/de not_active IP Right Cessation
- 1982-10-07 DE DE8282109252T patent/DE3276940D1/de not_active Expired
- 1982-10-07 EP EP82109252A patent/EP0077024B1/de not_active Expired
- 1982-10-12 IE IE2467/82A patent/IE54005B1/en unknown
- 1982-10-12 CA CA000413198A patent/CA1195325A/en not_active Expired
- 1982-10-12 GB GB08229116A patent/GB2108499A/en not_active Withdrawn
- 1982-10-13 DK DK452682A patent/DK452682A/da not_active Application Discontinuation
- 1982-10-13 US US06/434,036 patent/US4466976A/en not_active Expired - Lifetime
- 1982-10-13 JP JP57178609A patent/JPS58109474A/ja active Pending
-
1984
- 1984-08-17 US US06/641,641 patent/US4585771A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3276940D1 (en) | 1987-09-17 |
| JPS58109474A (ja) | 1983-06-29 |
| DE3141063A1 (de) | 1983-04-28 |
| EP0077024B1 (de) | 1987-08-12 |
| US4466976A (en) | 1984-08-21 |
| ATE28872T1 (de) | 1987-08-15 |
| IE54005B1 (en) | 1989-05-10 |
| GB2108499A (en) | 1983-05-18 |
| EP0077024A2 (de) | 1983-04-20 |
| EP0077024A3 (en) | 1984-08-01 |
| IE822467L (en) | 1983-04-13 |
| CA1195325A (en) | 1985-10-15 |
| US4585771A (en) | 1986-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK452682A (da) | Hidtil ukendte imidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem | |
| EA200100766A1 (ru) | Хинолин-2-он замещенные гетероарильные производные, используемые в качестве противоопухолевых агентов | |
| BR0014137A (pt) | Composto, método para inibir a aurora 2 quinase em um animal de sangue quente, uso de um composto, e, composição farmacêutica | |
| ES539658A0 (es) | Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados | |
| NO810684L (no) | Fremgangsmaate ved fremstilling av indanderivater. | |
| FI914058A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi | |
| KR860005794A (ko) | 이미다졸 유도체의 제조방법 | |
| PT73280B (de) | Neue imidazol derivate verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate | |
| DK160686A (da) | Tri- og tetracycliske forbindelser | |
| NO890440L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater. | |
| ES2172294T3 (es) | Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2106439T3 (es) | 5-(piperazinilalquil)-1,5-benzotiazepinonas utiles como antagonistas de calcio. | |
| ATE123487T1 (de) | Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen. | |
| ES538896A0 (es) | Procedimiento de preparar derivados de fenilalanina | |
| ES8702399A1 (es) | Un procedimiento para preparar derivdos de 1,5-benzoxatiepina | |
| ATE70838T1 (de) | Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung. | |
| CA2213054A1 (fr) | Nouveaux derives de bis-imides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| DK104388A (da) | Hidtil ukendte 2-(2,3-dihydro-2-oxo-3-benzofuranyl)-eddikesyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
| IL59358A0 (en) | Thiazole derivatives,their preparation and pharmaceutical compositions containing them | |
| MY104048A (en) | New allylaminoethylazoles. | |
| ATA262787A (de) | Pharmazeutische verwendung einer 8-chlorobenzothiazepinverbindung | |
| FR2629456B1 (fr) | Derives des acides 7-(1-imidazolyl),1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropyl-3-quinoleincarboxylique, leur preparation et leur application en tant que medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |